Alfredo Tagarro
European University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alfredo Tagarro.
Influenza and Other Respiratory Viruses | 2011
Teresa del Rosal; F. Baquero-Artigao; Cristina Calvo; María José Mellado; Juan C. Molina; María del Mar Santos; María José Cilleruelo; Mercedes Bueno; Pilar Storch de Gracia; Covadonga Terol; M.A. Roa; Roi Piñeiro; Milagros García López-Hortelano; María Luz García-García; Sonia Rodríguez; María Penín; Alejandro Zarauza; Francisco Alvarado; Ana de Blas; Enrique Otheo; Alfonso Rodríguez; María Luisa Herreros; Alfredo Tagarro; Luis Grande; José Tomás Ramos; Irene Maté; Cristina Muñoz; Miguel Á. Zafra; María Pilar Romero-Gómez; Elia Pérez-Fernández
Please cite this paper as: del Rosal et al. (2011) Pandemic H1N1 influenza‐associated hospitalizations in children in Madrid, Spain. Influenza and Other Respiratory Viruses 5(6), e544–e551.
Pediatric Infectious Disease Journal | 2016
Alfredo Tagarro; Bote P; Sánchez A; Enrique Otheo; Sanz Jc; Sanz-Rosa D
Background: In the Region of Madrid, universal immunization with the 13-serotypes pneumococcal conjugate vaccine (PCV13) started in May 2010. In July 2012, public funding ceased. Vaccination coverage decreased from >95% to 82% in 2013 and to 67% in 2014. Our aim was to investigate the impact of PCV13 withdrawal from Madrid Region universal immunization program on the incidence of complicated pneumococcal bacteremia. Methods: We performed a multicenter retrospective cohort study, from 2009 to 2014. Participants were children aged <14 years with Streptococcus pneumoniae bacteremia. Complications were defined as any condition requiring intensive care or surgery. Sequelae were conditions lasting ≥90 days. Results: A total of 168 patients were recruited. One-fourth of both immunized and nonimmunized patients had complications. Global complications increased after PCV13 withdrawal. About 28% of PCV13 serotypes presented complications. Complications caused by PCV13 serotypes did not increase after July 2012. Non-PCV13 serotypes increased progressively from 2009 on, and 23% presented complications. A significant risk of complications was found for patients with meningitis, empyema, C-reactive protein >100 mg/L and serotype 1. A multivariate analysis indicated that complications were associated with meningitis and hospital admission after July 2012. Sequelae were significantly associated with children <2 years of age, meningitis and non-PCV13 serotypes. Conclusions: The incidence of complications caused by PCV13 serotypes did not increase 2 years after PCV13 withdrawal. Nevertheless, all-serotypes complications increased. The likely cause was that non-PCV13 serotypes (associated with meningitis) are on the rise.
Acta Paediatrica | 2018
María Luisa Herreros; Alfredo Tagarro; Araceli García-Pose; Aida Sánchez; Alfonso Cañete; Pablo Gili
This study evaluated using urine dipstick tests with the clean‐catch method to screen for urinary tract infection (UTI) in febrile infants under 90 days of age.
Enfermedades Infecciosas Y Microbiologia Clinica | 2011
Alfredo Tagarro; Susana Jiménez; Aida Sánchez; Alicia Arroyo; Javier Aracil; Alfonso Cañete
Paediatrics and Child Health | 2015
María Luisa Herreros; Alfredo Tagarro; Araceli García-Pose; Aida Sánchez; Alfonso Cañete; Pablo Gili
Pediatric Infectious Disease Journal | 2018
Luis Prieto; Begoña Santiago; Teresa del Rosal; Begoña Carazo; Ana Belén Jiménez; Beatriz Pérez-Gorricho; Felipe Rubio; Alfredo Tagarro; Daniel Blázquez; David Moreno-Pérez; María José Mellado; Fernando Baquero-Artigao
Journal of Acquired Immune Deficiency Syndromes | 2018
Alfredo Tagarro; Man Chan; Paola Zangari; Bridget Ferns; Caroline Foster; Anita De Rossi; Eleni Nastouli; María Ángeles Muñoz-Fernández; Diana M. Gibb; Paolo Giorgi Rossi; Carlo Giaquinto; Abdel Babiker; Clàudia Fortuny; Riccardo Freguja; Nicola Cotugno; Ali Judd; Antoni Noguera-Julian; María Luisa Navarro; María José Mellado; Nigel Klein; Paolo Palma
1st EPIICAL General Assembly meeting, 9-11 November 2017, Rome – Italy | 2018
Paola Zangari; Palma Patrizia Rosato; Nicola Cotugno; Alfredo Tagarro; I Pepponi; A De Rossi; L Kuhn; Savita Pahwa; Mark J. Cameron; Eleni Nastouli; S Watters; A G Marceline; Laura E. McCoy; D Persaud; A Violari; M Chan; Abdel Babiker; Caroline Foster; Jintanat Ananworanich; Carlo Giaquinto; Phillip Rossi
Open Forum Infectious Diseases | 2016
Enrique Otheo; Mario Rodríguez; Alfredo Tagarro; Carmen Vázquez; Ana Coca; María Dolores Martín; Javier González-Sainz; Juan Carlos Galán; Santiago Moreno
Open Forum Infectious Diseases | 2016
Enrique Otheo; Mario Rodríguez; Sinziana Stanescu; Ana Coca; María Dolores Martín; Javier González-Sainz; Juan Carlos Galán; Alfredo Tagarro